These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13682638)

  • 1. Studies on sulfation factor (SF) activity of human serum. The variation of serum SF with age.
    ALMQVIST S; RUNE I
    Acta Endocrinol (Copenh); 1961 Apr; 36():566-76. PubMed ID: 13682638
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on sulfation factor (SF) activity of human serum. Serum SF in hypopituitarism and acromegaly.
    ALMQVIST S; IKKOS D; LUFT R
    Acta Endocrinol (Copenh); 1961 Apr; 36():577-95. PubMed ID: 13682635
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on sulfation factor (SF) activity of human serum. Evaluation of an improved method for the in vitro bioassay of SE and the effect of glutamine and human growth hormone in the sytem.
    ALMQVIST S
    Acta Endocrinol (Copenh); 1961 Jan; 36():31-50. PubMed ID: 14448292
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on sulfation factor (SF) activity of human serum. Rate of decrease of serum SF after hypophysectomy.
    ALMQVIST S; FALKHEDEN T
    Acta Endocrinol (Copenh); 1961 Jun; 37():315-20. PubMed ID: 13682634
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on sulfation factor (SF) activity of human serum. Effect of human growth hormone on SF levels in pituitary dwarfism.
    ALMQVIST S
    Acta Endocrinol (Copenh); 1960 Nov; 35():381-96. PubMed ID: 13682639
    [No Abstract]   [Full Text] [Related]  

  • 6. The stimulative effect of pituitary growth hormone on S35-sulfate incorporation in the chick embryo femur in tissue culture.
    ITO Y; TAKAMURA K; ENDO H
    Endocrinol Jpn; 1959 Mar; 6(1):68-9. PubMed ID: 13652874
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of skeletal growth by sulfation factor.
    Daughaday WH
    Adv Intern Med; 1971; 17():237-63. PubMed ID: 4949905
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on sulfation factor (SF) activity of human serum. The effects of oestrogen and x-ray therapy on serum SF activity in acromegaly.
    ALMQVIST S; IKKOS D; LUFT R
    Acta Endocrinol (Copenh); 1961 May; 37():138-47. PubMed ID: 13682637
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone and radio-sulfate incorporation in costal cartilage. III. Characteristics of the growth hormone response.
    COLLINS EJ; BAKER VF
    Acta Endocrinol (Copenh); 1961 Jun; 37():176-82. PubMed ID: 13694750
    [No Abstract]   [Full Text] [Related]  

  • 10. THE GROWTH-HORMONE-DEPENDENT SULPHATION FACTOR IN SERUM OF UNTREATED DIABETICS.
    YDE H
    Lancet; 1964 Sep; 2(7360):625-6. PubMed ID: 14186154
    [No Abstract]   [Full Text] [Related]  

  • 11. Human somatomedin, the growth hormone dependent sulfation factor, is antilipolytic.
    Underwood LE; Hintz RL; Voina SJ; Van Wyk JJ
    J Clin Endocrinol Metab; 1972 Aug; 35(2):194-8. PubMed ID: 5072353
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth hormone activity in human pregnancy. I. Serum sulfation factor.
    CHESLEY LC
    Am J Obstet Gynecol; 1962 Oct; 84():1075-80. PubMed ID: 14020666
    [No Abstract]   [Full Text] [Related]  

  • 13. Some biological properties of purified sulfation factor (SF) from human plasma.
    Hall K; Uthne K
    Acta Med Scand; 1971; 190(1-2):137-43. PubMed ID: 5099123
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor.
    New MI; Schwartz E; Parks GA; Landey S; Wiedemann E
    J Pediatr; 1972 Apr; 80(4):620-6. PubMed ID: 5015070
    [No Abstract]   [Full Text] [Related]  

  • 15. GH and bone metabolism: the role of the vitamin D system.
    Pfeilschifter J
    Eur J Endocrinol; 1997 Jan; 136(1):30-2. PubMed ID: 9037120
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors.
    Finkelstein JW; Kream J; Ludan A; Hellman L
    J Clin Endocrinol Metab; 1972 Jul; 35(1):13-7. PubMed ID: 4113389
    [No Abstract]   [Full Text] [Related]  

  • 17. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
    SALMON WD; DAUGHADAY WH
    J Lab Clin Med; 1957 Jun; 49(6):825-36. PubMed ID: 13429201
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage.
    Froesch ER; Zapf J; Audhya TK; Ben-Porath E; Segen BJ; Gibson KD
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2904-8. PubMed ID: 1066701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of growth hormone-dependent human serum sulfation factor by estrogen.
    Wiedemann E; Schwartz E
    J Clin Endocrinol Metab; 1972 Jan; 34(1):51-8. PubMed ID: 5008233
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bone metabolism and hormone, with special reference to somatotropin].
    Inoue T
    Nihon Seikeigeka Gakkai Zasshi; 1970 Sep; 44(9):689-92. PubMed ID: 5531134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.